CGEM · Categories · Form 5

CGEM - SEC Form 5 annual insider statements

Cullinan Therapeutics Inc. (CGEM) sec form 5 annual insider statements - real-time wire coverage filtered to Form 5 only.

Recent Form 5 for CGEM

• 1215d
  SEC Form 5: Gadicke Ansbert increased direct ownership by 144% to 595,489 units

  5 - Cullinan Oncology, Inc. (0001789972) (Issuer)

Other CGEM categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• DEF 14A
• M&A
• Earnings
• Dividends